Novavax
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $239,240 | $666,655 | $88,311 | $84,512 |
Gross Profit | 225,015 | 652,540 | 51,642 | 23,893 |
EBITDA | 120,535 | 533,909 | -53,479 | -105,396 |
EBIT | 112,972 | 525,569 | -65,996 | -118,096 |
Net Income | 106,508 | 518,646 | -81,030 | -121,300 |
Net Change In Cash | 239,240 | 666,655 | 88,311 | 84,512 |
Free Cash Flow | -127,709 | -186,722 | -175,415 | -145,564 |
Cash | 264,493 | 263,338 | 530,230 | 573,630 |
Basic Shares | 177,215 | 177,625 | 160,241 | 160,049 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $682,162 | $556,382 | $1,598,951 | $1,146,290 |
Gross Profit | 479,423 | 212,614 | 696,312 | 1,146,290 |
EBITDA | -108,044 | -487,390 | -604,713 | -1,673,915 |
EBIT | -156,540 | -528,615 | -633,767 | -1,686,576 |
Net Income | -187,499 | -545,062 | -657,939 | -1,743,751 |
Net Change In Cash | 682,162 | 556,382 | 1,598,951 | 1,146,290 |
Cost of Revenue | 884,813 | |||
Free Cash Flow | -100,320 | -772,773 | -508,922 | 265,460 |
Cash | 530,230 | 568,505 | 1,336,883 | 1,515,116 |
Basic Shares | 152,190 | 100,768 | 78,183 | 74,400 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.62 |
2025-03-31 | $2.93 |
2024-12-31 | -$0.52 |
